MIP-1095 I-123 Uses, Dosage, Side Effects and more
123 I Mip 1095 is under investigation in clinical trial NCT00712829 (Study to Evaluate the Safety, Pharmacokinetics, Tissue Distribution, Metabolism and Dosimetry of Two Prostate Cancer Imaging Agents).
| Attribute | Details |
|---|---|
| Trade Name | MIP-1095 I-123 |
| Generic | MIP-1095 I-123 |
| Type | |
| Formula | C19H25IN4O8 |
| Weight | Average: 560.335 Monoisotopic: 560.072836725 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
